image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

BTG

December 2003

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BGC
Technology development group, BTG put out some very mixed news.  There was some encouragement from the announcement that it would  be paid £12m as a final settlement relating to its claim toentitlement to 2% of  Acambis' turnover.  However, this was overshadowed by the US Food & Drug Administration's decision to place Varisolve's phase II safety study on clinical hold. Although the FDA hasn't yet given its reasons,  it will be writing to the company in due course.  Meanwhile, European Phase III trials are continuing. As Varisolve is BTG's lead drug, with high hopes ofeventually achieving peak sales of £300m, investors took the news verybadly.  However, even if Varisolve is written off (by ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

BTG - Blockbuster hopes for new varicose vein treatment (July 2008)
BTG - Varisolve may float next year (October 2003)
BTG - Likely beneficiary when IPO window re-opens (September 2003)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe

SUBSCRIBE NOW